Guanylin peptides: renal actions mediated by cyclic GMP.
The guanylin family of cGMP-regulating peptides has three subclasses of peptides containing either three intramolecular disulfides found in bacterial heat-stable enterotoxins (ST), or two disulfides observed in guanylin and uroguanylin, or a single disulfide exemplified by lymphoguanylin. These small, heat-stable peptides bind to and activate cell-surface receptors that have intrinsic guanylate cyclase (GC) activity. Two receptor GC signaling molecules have been identified that are highly expressed in the intestine (GC-C) and/or the kidney (OK-GC) and are selectively activated by the guanylin peptides. Stimulation of cGMP production in renal target cells by guanylin peptides in vivo or ex vivo elicits a long-lived diuresis, natriuresis, and kaliuresis. Activation of GC-C receptors in target cells of intestinal mucosa markedly stimulates the transepithelial secretion of Cl(-) and HCO(-)/(3), causing enhanced secretion of fluid and electrolytes into the intestinal lumen. Bacterial ST peptides act as mimics of guanylin and uroguanylin in the intestine, which provide a cellular mechanism underlying the diarrhea caused by ST-secreting strains of Escherichia coli. Uroguanylin and guanylin may participate in a novel endocrine axis linking the digestive system and kidney as a physiological mechanism that influences Na(+) homeostasis. Guanylin, uroguanylin, and/or lymphoguanylin may also serve within intrarenal signaling pathways controlling cGMP production in renal target cells. Thus we propose that guanylin regulatory peptides participate in a complex multifactorial biological process that evolved to regulate the urinary excretion of NaCl when dietary salt levels exceed the body's physiological requirements. This highly integrated and redundant mechanism allows the organism to maintain sodium balance by eliminating excess NaCl in the urine. Uroguanylin, in particular, may be a prototypical "intestinal natriuretic hormone."
Forte
L R
LR
Harry S. Truman Memorial Veterans' Hospital, School of Medicine, Missouri University, Columbia, Missouri 65212, USA. lrf@misouri.edu
London
R M
RM
Freeman
R H
RH
Krause
W J
WJ
D000818:Animals; D006152:Cyclic GMP / Q000502:physiology*; D005768:Gastrointestinal Hormones; D006162:Guanylate Cyclase / Q000502:physiology; D006801:Humans; D007413:Intestinal Mucosa / Q000502:physiology*; D007668:Kidney / Q000502:physiology*; D045265:Natriuretic Peptides; D010455:Peptides / Q000502:physiology*; D018000:Receptors, Peptide / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology
D005768:Gastrointestinal Hormones; D045265:Natriuretic Peptides; D010455:Peptides; D018000:Receptors, Peptide; C118275:lymphoguanylin; C072685:guanylin; C084362:uroguanylin; D006162:Guanylate Cyclase; D006152:Cyclic GMP